South Bow (NYSE:SOBO – Get Free Report) had its target price increased by research analysts at Scotiabank from $24.00 to $26.00 in a research report issued on Thursday, Marketbeat reports.

Large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. acquired a new position in South Bow in the 4th quarter valued at about $206,467,000. ClearBridge ...

Scotiabank raised the firm’s price target on South Bow (SOBO) to $26 from $24 and keeps a Sector Perform rating on the shares. The firm is introducing its 2027 estimates for its Canadian energy ...

Kelly meets Timothy, a Broadway understudy who recently went viral for giving his parents a traditional Korean bow after his ...

North Korea warns of retaliation after ... OpenAI joins forces with South Korean tech giant Kakao after DeepSeek scare OpenAI’s CEO Sam Altman has signed a deal with South Korean tech giant ...

South Korean actress Kim Sae-ron has been found dead at her home in Seoul, according to the Yonhap news agency. A friend discovered the Netflix actress after going to her house. They called the ...

The Archdiocese of Seoul in South Korea has reached “the era of 1,000 priests” upon ordaining 26 new priests for the local Church on Feb. 7. Archbishop Peter Chung Soon-taick, who presided ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

CALGARY, Alberta, Feb. 05, 2025 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) will release its fourth-quarter and year-end 2024 financial and operational ...

Porsche Korea CEO Mathias Busse pledges to double service ... of strategists and foresight practitioners predicted that South Korea will have nuclear weapons within the next decade, a think ...

The report said it was the United States that was engaging in confrontational behaviour such as planning war exercises with South Korea and sending a nuclear submarine to the Korean Peninsula.

“Our focus has always been on addressing the root causes of skin concerns,” said Jang Yoon-sung, CEO of Pharmearth, during a recent interview with The Korea Herald. “Lately, we have seen an ...